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Establishment of an isotope dilution LC-MS/MS method revealing kinetics and distribution of co-occurring mycotoxins in rat

Introduction
Mycotoxins, as the toxic secondary metabolites produced by various mold species, can contaminate many agricultural commodities in the field or during storage [1] [2] [3] . Typically, aflatoxin B1 (AFB1) and T-2 toxin (T-2), as frequently co-occurring mycotoxins in natural incidence, are produced by Aspergillus and Fusarium species, respectively [4] [5] [6] . AFB1 is a highly toxic and carcinogenic compound that causes disease in livestock and humans, and has been classified in group І as human carcinogen [7] [8] [9] . Due to its hepatotoxic and hepatocarcinogenic properties, the content of AFB1 in foods is strictly restricted in many countries 10 . T-2 can cause both acute and chronic diseases such as vomiting, diarrhea, skin irritation, weight loss, feed refusal and nausea, as well as neural disturbances and abortion [11] [12] [13] . Even so, up to now, no regulatory levels on public have been set for T-2 worldwide.
Practically, humans can be co-exposed to two representative mycotoxins of AFB1 and T-2.
First, the same food can be infected or invaded by different mycotoxigenic molds resulting in the co-occurring AFB1 and T-2 even at high concentrations in many geographic origins under optimum environmental conditions [14] [15] [16] ; Second, co-occurring mycotoxins can reach humans through the various diets and also, through milk, meat and eggs from livestock and poultry animals fed with different mycotoxins contaminated feedstuffs [17] [18] [19] . The toxic effects, appearing in consumers exposed to co-occurring mycotoxins, are surely in accordance to the possible interactions of concomitantly occurring mycotoxins, which might be antagonistic, additive, or synergistic on different occasions 20 . Nevertheless, knowledge regarding to the influence of co-occurring AFB1 and T-2 on kinetics and distribution is still unknown to date, where the main technical obstacle is the scare of simple, accurate and highly sensitive means capable of quantifying target mycotoxin molecules from complicated biological samples.
Therefore, development and validation of desirable analytical methods for the simultaneous determination of co-occurring AFB1 and T-2 in a variety of biomatrices are very valuable, which are also the reliable tools for the kinetic and distribution studies to reveal the bidirectional effects of co-occurring AFB1 and T-2 in experimental animal system, minimizing the use of laboratory animals and the cost of analysis, with the premise of accuracy and precision.
Various methods have been employed to individually analyze single mycotoxin of either AFB1 or T-2 in biological fluids and tissues. These generally include radioactivity, thin-layer chromatography (TLC) and high performance liquid chromatography (HPLC) combined with different detectors 8, [21] [22] [23] [24] [25] [26] [27] [28] . Radioactivity is very sensitive, which can be utilized in mass balance and tissue distribution studies, but not suitable for kinetic analysis due to the serious interferences of the extensive metabolites 29 . TLC and HPLC coupled to UV or fluorescence detectors (FLD) could supply acceptable sensitivity in premise of tedious derivation process due to the weak chromophore of analyzed mycotoxins. Since the latest decade, liquid chromatography tandem mass spectrometry (LC-MS/MS) plays a pivotal role in trace analysis of multiple mycotoxins because of its high sensitivity and selectivity [30] [31] [32] . However, molecules originating from the sample matrix that co-elute with the compounds of interest may have significant impact on the ionization process causing ionization suppression/enhancement, and consequently on the accuracy of the method. Namely, the two main limiting features when detecting multiple mycotoxins in different biomatrices are the variety of the physico-chemical properties of the involved mycotoxins and the complex composition of sample matrix. Hitherto, although several LC-MS/MS methods have already been developed for simultaneous determination of AFB1 and T-2 in food and feedstuffs 7 , no uniform method with sufficient simplicity, relative rapidity and high sensitivity has been reported, which could be applicable for different biomatrices i.e., plasma, heart, liver, spleen, lung, kidney and brain, with the complicated substances as interferences.
In the present study, a simple and sensitive LC-MS/MS method based on a combination of isotope dilution and fast sample preparation using homemade clean-up cartridges was developed and then validated for simultaneous quantitation of co-occurring AFB1 and T-2 in rat plasma, heart, liver, spleen, lung, kidney and brain. The utmost advantage of this proposed analytical method is that identical conditions can be utilized for analyzing AFB1 and T-2 in all the above mentioned biomatrices. Furthermore, the small amount of sample needed, the low volume of solvents used and the fact that immunoaffinity columns (IAC) are not required for this assay, making it more rapid, economical and practical for analyses of AFB1 and T-2 in such small animal experiments. This method was then successfully applied to the kinetics and tissue distribution studies after oral administration of co-occurring AFB1 and T-2 in rat system, demonstrating its potential for toxicological or toxicokinetic studies.
Experimental section
Safety precautions AFB1 and T-2 are toxic substances, which should be manipulated in solution, avoiding the formation of dust and aerosols. FPP3 masks and nitrile gloves were used when all related procedures were carried out.
Chemicals and reagents
The standards of AFB1 (molecular weight (MW), 312), T- 
Standard solutions
Accurately weighed solid portions (1.0 mg) of AFB1 and T-2 were dissolved in 2 mL of pure ethanol, and the solution was diluted with water to prepare a mixture of AFB1 and T-2 at a concentration of 0.1 mg mL -1 in 20% of ethanol aqueous solution, which was used for the oral administration of rats. 
Animals
Male Sprague-Dawley (SD) rats, weighing 200±20 g, were purchased from Fudan University Laboratory Animal Center (Shanghai, China). The study was approved by the Animal Ethics
Committee of Shanghai Academy of Agricultural Sciences.
On the day of arrival, the animals were randomly distributed to polycarbonate cages with stainless steel covers for one week to allow acclimatization to the environmental conditions:
12 h day/night cycle, temperature 25±2
• C, standard diet and water.
For the kinetics studies in plasma, six rats were administrated one single dose of 0. For the tissue distribution studies, fifty four rats were randomly divided into nine groups (n = 6) and administrated an oral dose of 0.5 mg/kg b.w. AFB1 and T-2 by gavage. After euthanizing by cervical dislocation prior to dosage (0 h) and at 0.5 h, 1 h, 2 h, 4 h, 12 h 24 h, 48 h and 72 h thereafter, the tissues of heart, liver, spleen, lung, kidney and brain were excised and blot dried. In order to minimize the differences generated from various cell types in the organs and take a representative sample, the whole tissues were individually homogenized with normal saline (m/v, 1/3), and the homogenates were stored at −20 • C until analysis.
For investigation of tissue accumulation, six rats received a daily administration of 0.25 mg/kg b.w. AFB1 and T-2 by oral gavages during 20 days, while another six rats were administrated with normal saline as control. The animals were euthanized 24 h after the last administration, and the tissues were dealt as described above.
Preparation of homemade clean-up cartridges
Silica gel (0.09 g) was accurately weighed into a 3 mL hollow SPE cartridge and was shaken to compact the silica gel. Then, 0.01 g of florisil was added. After shaking, florisil was then covered by a frit at the end to ensure the upper surface smooth and flat.
Sample pretreatment
To the plasma/tissue homogenates (100 μL), 10 μL of IS solution (50 ng mL −1 ) was added, were appropriately diluted with blank plasma/tissue homogenates and 100 μL of the dilution was selected and processed as described above.
Method validation
The method was thoroughly validated on a serial of characteristics of specificity, linearity, sensitivity, extraction recovery, accuracy and precision. Matrix effects as well as the stability of AFB1 and T-2 in plasma and tissue homogenates were also determined.
Specificity was demonstrated by comparing chromatograms of blank plasma/tissue homogenates, plasma/tissue homogenates spiked with AFB1 and T-2, and plasma/tissue homogenates collected after the oral administration.
Calibration curves of seven data points were plotted in the range of 0.05-100 ng mL -1 in solvent, plasma, heart, liver, spleen, lung, kidney and brain, respectively, and 5 ng mL -1 of each IS was included in each solvent. The sensitivity was evaluated by determining the lower limit of detection (LLOD) and lower limit of quantitation (LLOQ). The LLOD and LLOQ were defined as the concentrations of AFB1 and T-2 that yielded a signal-to-noise (S/N) ≥3
and ≥10, which were both determined by decreasing the spike concentrations in various biomatrices, respectively.
Extraction recovery was assessed using a generic SPE extraction procedure with four spiked levels (0.05, 1, 10, 100 ng mL -1 ). Recovery data were determined by comparing the peak areas (n = 6, each concentration) of AFB1 and T-2 obtained from plasma/ tissue homogenates spiked before extraction with that from plasma/ tissue homogenates spiked after extraction. Precision was evaluated by determining the same spiked samples in one day (intra-day precision) and the samples spiked with the same concentrations in four consecutive days (inter-day precision).
The stability of AFB1 and T-2 in plasma and tissue homogenates was investigated by analyzing extracted samples at two spiked levels of 1 and 10 ng mL -1 stored at room temperature (RT) for 8 h, at -20°C for two weeks and three successive freeze-thaw cycles.
Stability was assessed by comparing the mean concentrations of AFB1 and T-2 in the stored samples with those of the freshly prepared ones.
Data analysis
All kinetic parameters were processed by Drug and statistics (DAS) software, 
Results and discussion
Optimization of the LC-MS/MS conditions
The MS/MS conditions were firstly optimized for AFB1 or T-2 by individual injection of each standard solution (500 ng mL -1 Table 1 .
A mixture of methanol and water was used as the mobile phase for separation of AFB1 and T-2. After optimization, a satisfactory separation for AFB1 and T-2 was generated by linear gradient elution. In order to achieve high sensitivity of analysis, the ionization efficiency was investigated by further optimization of the composition of the mobile phase. Since ESI + was employed in the present study, the acidic conditions would be beneficial to the ionization of the analytes. Therefore, water containing 0.05% formic acid, water containing 10 mmol L ammonium acetate were added compared to other additives. Under such situation, nice peak shapes and satisfactory separation efficiency were also achieved.
Development of the homemade clean-up cartridges
In general, matrix effects were directly related to an insufficient sample clean-up and might be reduced by simply injecting smaller volumes or diluting the sample, which seriously influence the sensitivity of the method, and were therefore inappropriate in the present study. In literature, IAC columns, Multisep multifunctional cartridges and Mycosep multifunctional cartridges are frequently used for mycotoxin purification 31, 32, 34 . However, no commercially available cartridges were reported with acceptable capability for simultaneous determination of AFB1 and T-2 in plasma and different tissue homogenates.
In the present study, six commercially available normal-phase materials, which were commonly used for the purification of the analytes in the previous studies, i.e., silica gel, active carbon, alumina neutral, alumina base, florisil and kieselguhr, were tested for their purification efficiencies. First, the recovery performance of all candidates was evaluated by purifying mixed standard solutions (1.5 ng mL -1 ) with the cartridges filled with one single material (0.1 g). The mixed solutions (100 μL) were passed through the cartridges and eluted with 3 mL of methanol. The eluent was collected and dried by nitrogen gas at 40 • C. The residues were re-dissolved in 100 μL of mixed solution of acetonitrile and water containing 10 mmol L -1 ammonium acetate (20/80, v/v). As indicated in Fig. 1 , silica gel and florisil showed satisfactory recoveries (>80%). An orthogonal design L 9 (3 4 ) was conducted to optimize the ratio of silica gel to florisil, quantity of total materials and quantity of the elution solvent. The factors and levels were designed as shown in 
2). As shown in Online
Resource 2, all of the three factors had significant effects on AFB1 and T-2 purification since the F values were all greater than the critical F value (19, P=0.05). The total content of AFB1 and T-2 was highest when the ratio of silica gel to florisil was selected as 9/1, quantity of total materials was 0.1 g and quantity of the elution solvent was 3 mL. Consequently, a simple sample purification approach based on the homemade clean-up cartridges was developed.
Afterwards, spiked plasma and different tissue homogenates were further tested. It could be obviously seen from the results that the sensitivities were significantly improved for AFB1
and T-2 when the spiked extracts were purified with homemade mixed cartridges. On the other hand, some impurities, i.e., pigment and protein, which could reduce the lifetime of the analytical columns, were eliminated by the SPE cartridges. Satisfactory purification efficiencies evaluated by determining the matrix effects and the presence of interference peaks, and high recoveries were generated, supporting the strong ability of the homemade clean-up cartridges for the purification of co-occurring AFB1 and T-2 in different biomatrices.
Method validation
The method was selective for plasma and six different tissue homogenates since no interference peaks appeared at the retention time of AFB1 or T-2 in blank samples, also indicating that no AFB1 or T-2 existed in the regular rat feed. Chromatograms of blank plasma (a) and liver (d), blank plasma (b) and liver (e) spiked with AFB1 and T-2 (50 ng mL (Table 2 ). For both mycotoxins in plasma and tissue homogenates, the LLOD and LLOQ were 0.01 and 0.05 ng mL -1 , respectively (Table 2) , which were desirable and obviously lower than those obtained in bibliography via UHPLC-FLD approaches 35 .
The observed matrix effects without ISs correction ranged from 73.0 to 105.8% for AFB1 and from 74.9 to 88.6% for T-2, suggesting that matrix effects in quantitative analysis could not be ignored. In order to establish an accurate method suitable for determination of co-occurring AFB1 and T-2 in different matrices, ISs were needed to correct the recovery losses during the ionization process. were in the range of 90.2-108.9% for AFB1 and 90.9-100.0% for T-2, respectively, demonstrating that signal suppression/enhancement could be eliminated by the two ISs (Table   3 ).
The extraction recoveries of AFB1 and T-2 at LLOQ, low, intermediate and high concentrations (0.05, 1, 10 and 100 ng mL -1 ) were in the range of 51.6-111.3% for AFB1 and 68.9-103.8% for T-2, respectively (Table 4) . In order to minimize the losses of AFB1 and T-2 during the extraction process on some occasions, the isotope ISs were utilized in the present work. As a consequence, desirable accuracy of the method ranged from 70.9 % to 107.7% for AFB1 and from 72.4% to 108.3% for T-2 was obtained (Table 4) . Values for the precision were no more than 12.3% (intra-day) and 13.4% (inter-day) for AFB1, and 11.6% (intra-day) and 14.2% (inter-day) for T-2, respectively ( Table 5 ).
The stability of AFB1 and T-2 in rat plasma and tissue homogenates was fully evaluated. As summarized in Table 6 , the results of short-term, freeze-thaw and long-term stabilities showed that all the samples were stable under these conditions, indicating there were no stability-related problems during the routine and large-scale analysis of bulk samples.
Comparatively, this proposed simple uniform LC-MS/MS method for simultaneous determination of AFB1 and T-2 in different biomatrices showed higher sensitivity and faster sample preparation, as well as more accuracy aided by isotope ISs than the previously reported methods.
In vivo kinetics and distribution studies
The oral dose for administration was ascertained based on the data from some pilot experiments and previous literatures 29, 36 , and was obviously lower than the reported median lethal dose (LD 50 ) of AFB1 (5.5-17.9 mg/kg b.w. by oral) or T-2 (0.9 mg/kg b.w. by intravenous) in rat. The developed LC-MS/MS method was employed for kinetics investigation of co-occurring AFB1 and T-2 in rat plasma after oral administration at a dose of 0.5 mg/kg b.w. The concentration-time profiles are presented in Fig. 3 . The calculated kinetic parameters expressed as mean ± SD are shown in Table 7 . After oral administration, the highest concentration of AFB1 (Cmax= 16.58±1.05 ng mL -1 ) was observed with Tmax being 0.17 min. In previous studies, the obtained time-to-peak for AFB1 in rat was in the range of 2-3 h 37, 38 . These existed differences might be due to two possibilities. First, different analytical techniques were utilized. The total radioactivity employed in the previous studies might misidentify the target analytes with the metabolites and other impurities 29 , while LC-MS/MS with high selectivity was developed in the present study and could eliminate the false positive results; second, the co-occurring AFB1 and T-2 might accelerate the distribution of AFB1 showing the additive toxic effects 20 . The concentrations of T-2 in rat plasma were lower than that of AFB1, with a Cmax of only 0.53±0.08 ng mL -1 . As previously reported, only about 2% of the dose appeared in the effluent during the metabolism experiment of tritiated T-2 toxin (2.3 and 230 pg) in vascularly autoperfused jejunal loops of rats 29 .
Similarly, it could be concluded in this study that T-2 toxin was susceptible to liver and intestinal first-pass effects, so that its absolute bioavailability might be negligible following oral administration.
The concentration-time profiles in different tissues analyzed at 0-72 h after oral administration are shown in Fig. 4 . The results indicated that AFB1 underwent a rapid distribution in the tissues. Within 1 h after administration, highest concentrations of AFB1
were reached in all of the target tissues. Then, AFB1 was rapidly eliminated and disappeared within 24 h. Interestingly, AFB1 was also detected in brain homogenate, demonstrating that AFB1 could efficiently cross the blood-brain barrier. For T-2, very low concentrations were observed in heart, liver, spleen, lung, kidney, and disappeared within 4 h in all tissues, also indicating its low absolute bioavailability. As to tissue accumulation of AFB1 and T-2 ( Table 3 The extents of signal suppression/enhancements (SSEs) calculated using the isotope ISs or not (%, n=3). Table 7 Pharmacokinetic parameters of AFB1 and T-2 (0.5 mg/kg b.w.) after oral administration in rat (n = 6). 
